4//SEC Filing
ARATANA THERAPEUTICS, INC. 4
Accession 0001209191-16-130585
CIK 0001509190operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:08 PM ET
Size
7.3 KB
Accession
0001209191-16-130585
Insider Transaction Report
Form 4
Standridge Brent
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-07-01+83,333→ 83,333 totalExercise: $6.46Exp: 2026-06-30→ Common Stock (83,333 underlying) - Award
Common Stock
2016-07-01+41,667→ 66,667 total
Footnotes (1)
- [F1]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on July 1, 2017 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on July 1, 2020, subject to continued service with the Issuer through the applicable vesting dates.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001509190
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:08 PM ET
- Size
- 7.3 KB